Viveon Health Acquisition Corp.: directors' dealings · United States · SEC (Form 4)

About Viveon Health Acquisition Corp.

Viveon Health Acquisition Corp. is a U.S.-listed SPAC trading on NYSE American under the ticker VHAQ, with related securities including VHAQW, VHAQR, and VHAQU. The company was incorporated in Delaware on August 7, 2020, and was formed as a blank-check vehicle to complete a merger, share exchange, asset acquisition, stock purchase, recapitalization, or similar business combination. Its stated focus has been healthcare, with an emphasis on targets whose primary operations are located in North America, particularly the United States. For investors, that means Viveon should be viewed less as a traditional operating company and more as a transaction platform whose value depends on deal execution. As a SPAC, Viveon has not operated a standalone commercial business or generated meaningful operating revenue of its own. Its SEC filings indicate that its activities have consisted primarily of organizational work, capital raising, and the search for a suitable acquisition target. Any economic income at the shell-company stage has been non-operating in nature, mainly interest income on cash and marketable securities. In practical terms, the company’s competitive position is not measured by product sales or market share, but by its ability to source an attractive healthcare asset, negotiate terms, secure shareholder approval, and close the transaction on schedule. The most important recent strategic development has been Viveon’s announced business combination path with Clearday, a San Antonio, Texas-based healthcare services company. Public announcements in 2024 reaffirmed the parties’ intention to move forward with that transaction, with Clearday positioned around longevity care and digital companionship solutions for aging consumers. That makes Viveon’s investment case highly event-driven: the outcome will depend on the quality of the target, the final deal structure, regulatory and stockholder approvals, and the post-merger capitalization. For market participants tracking Form 4 insider activity, such filings can be useful clues about management alignment and confidence, but they should be read in the context of a SPAC’s broader transaction cycle. Geographically, Viveon is a United States company incorporated in Delaware, with management references tied to Georgia, while the announced target operates in Texas. It does not have a broad international operating footprint in the conventional sense; its footprint is financial, legal, and transactional. In summary, Viveon Health Acquisition Corp. is a healthcare-focused SPAC listed in the United States on NYSE American, with its future value tied primarily to the successful completion and market reception of its business combination rather than to an existing operating platform.